翻訳と辞書 |
Cost of HIV treatment : ウィキペディア英語版 | Cost of HIV treatment The cost of HIV treatment is a complicated issue because of the high cost of developing HIV treatments versus an urgent lifesaving need across cultural boundaries to access HIV treatments. One way to state the issue would be to say that the treatments, typically drug regimens, are the products of extremely costly and resource intensive clinical research. Once the research is complete, the actual cost of the drugs is much lower. Many people living with HIV need the drugs to save their lives, but are unable to afford them at the market cost. If the drug developers do not recover market cost, then they lose their research investment and certainly have no motivation to invest further in research. However, most people who need HIV treatment are unable to contribute monetarily in any significant way to the cost of their drugs, so either they need to get the drugs at a nominal cost or no cost or they will suffer death. Governments and private institutions have created various financial schemes to subsidize the cost of HIV treatment to make it as accessible as possible to the people who need it while encouraging financial motives to grow the HIV research sector. When those schemes have not been effective people have protested or reacted in different ways. ==Scheme for drug pricing== Drug companies marketed their drugs at different prices depending on the target consumers. In the United States many people accessed healthcare through private insurers which they paid through their employers, and in this system, the market could pay extremely high drug prices.〔 In wealthy countries with nationalized healthcare, like Canada, Western Europe, and Japan, the drug companies charged mid-range prices according to the market norms.〔 In developing countries the prices were lowest.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Cost of HIV treatment」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|